Please assess the completion status of the following clinical trial:

Trial Title: ED95 of Lidocaine 1.0% for Filling the Adductor Canal

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~* 18-30 years~* Men~* American Society of Anesthesiologists' class 1~* Body Mass Index 18-25~Exclusion Criteria:~* Allergy to study medication~* Earlier trauma or surgery to the lower limb~* Diabetes Mellitus - Contraindications to MRI

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 30 Years
- Healthy Volunteers: t

Study Arms:
- ACB with 30 ml lidocaine 1% (Type: EXPERIMENTAL): Procedure/Surgery: Adductor canal block with lidocaine 1% The Continual Reassessment Method is used to calculate the dose level consecutively for every new cohort (2 subjects) in the study.~Possible dose levels are: 5, 10, 15, 20, 25 and 30 ml.
- ACB with 25 ml lidocaine 1% (Type: EXPERIMENTAL): Procedure/Surgery: Adductor canal block with lidocaine 1% The Continual Reassessment Method is used to calculate the dose level consecutively for every new cohort (2 subjects) in the study.~Possible dose levels are: 5, 10, 15, 20, 25 and 30 ml.
- ACB with 20 ml lidocaine 1% (Type: EXPERIMENTAL): Procedure/Surgery: Adductor canal block with lidocaine 1% The Continual Reassessment Method is used to calculate the dose level consecutively for every new cohort (2 subjects) in the study.~Possible dose levels are: 5, 10, 15, 20, 25 and 30 ml.
- ACB with 15 ml lidocaine 1% (Type: EXPERIMENTAL): Procedure/Surgery: Adductor canal block with lidocaine 1% The Continual Reassessment Method is used to calculate the dose level consecutively for every new cohort (2 subjects) in the study.~Possible dose levels are: 5, 10, 15, 20, 25 and 30 ml.
- ACB with 10 ml lidocaine 1% (Type: EXPERIMENTAL): Procedure/Surgery: Adductor canal block with lidocaine 1% The Continual Reassessment Method is used to calculate the dose level consecutively for every new cohort (2 subjects) in the study.~Possible dose levels are: 5, 10, 15, 20, 25 and 30 ml.
- ACB with 5 ml lidocaine 1% (Type: EXPERIMENTAL): Procedure/Surgery: Adductor canal block with lidocaine 1% The Continual Reassessment Method is used to calculate the dose level consecutively for every new cohort (2 subjects) in the study.~Possible dose levels are: 5, 10, 15, 20, 25 and 30 ml.

Based on this trial design, predict the completion outcome and termination type (if applicable).